Early detection and intervention are key for treating childhood on-set disorders. In an effort to create awareness about the same, LifeCell, India’s largest stem cell bank announced special offers on its newborn screening package. Aligned with Rare Disorder Awareness month, the offer encourages parents to enrol with LifeCell and have their newborn babies screened for life-threatening ailments with additional upgrades at no cost.  

Newborn screening is a programme that identifies babies at risk of having rare, but serious medical conditions that can affect normal development. BabyShield Newborn Screening combines biochemical testing of 100+ metabolic & genetic conditions with confirmatory genetic testing for screen-positive results. It aims to achieve the early identification of conditions.

Thus, resulting in early intervention that can lead to efficient management and diagnosis and thereby reducing the economic liability too. LifeCell’s NBS is the world’s first integrated DNA testing for newborn screening to detect over 50 medical conditions.

This technology has been proven to be more accurate than current screening methods and has also been found to drastically reduce false-positive reporting thereby avoiding unnecessary follow-up tests and anxiety of the parents. The test provides more accurate results and also saves time & effort enabling a speedy diagnosis to initiate treatment. More importantly, the parents are alerted to the risk only if the DNA tests are positive thereby reducing parental anxiety.